FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to field of pharmaceutics and medicine and deals with application of tiotropium bromide salt for obtaining medication, intended for treatment of patients, who suffer from severe form of persistent asthma.
EFFECT: invention insures high efficiency of treatment.
11 cl, 1 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2568882C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ARFORMOTEROL AND FLUTICASONE FUROATE | 2013 |
|
RU2678992C2 |
COMBINATIONS CONTAINING ANTI-MUSCARINE PREPARATIONS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2379033C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2642624C2 |
COMBINATIONS CONTAINING ANTIMUSCARINE AGENTS AND CORTICOSTEROIDS | 2005 |
|
RU2385156C2 |
COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2404771C2 |
NOVEL METHODS | 2008 |
|
RU2484821C2 |
PHARMACEUTICAL AEROSOL COMPOSITION | 2009 |
|
RU2565438C2 |
COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | 2010 |
|
RU2586297C2 |
CRYSTALLINE LEVOSALBUTAMOL SULFATE, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH CONTAINS IT | 2005 |
|
RU2440972C2 |
Authors
Dates
2011-06-27—Published
2006-08-02—Filed